Keywords: Market forecasts, Margins, Generic drug business, M&A, Espicom, Pressures

Global generic drug markets will grow to $221 billion by 2016; Espicom

Article | 29 April 2012

The economic recession has been a double-edged sword for the international generic drugs business. Driven by the need to control ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in